Used in pharmaceutical HPLCMS analysis for nitrosamine impurity profiling to ensure drug safety per FDAEMA guidelines on genotoxic impurities.

It serves as a critical reference standard for detecting and quantifying nitrosamine impurities during quality control and regulatory compliance testing of ipratropium bromide an anticholinergic bronchodilator.

N-Nitroso Ipratropium Bromide Impurity is a nitrosamine process impurity of the anticholinergic drug Ipratropium Bromide featuring an N-NO group on the tropane nitrogen.